Clinical Trial Update: An Intermediate Expanded Use Trial of DFMO

View source ↗

Summary

This is an update on an intermediate expanded-use trial of DFMO for neuroblastoma and several embryonal CNS tumors, including medulloblastoma, ATRT, ETANTR, epe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Embryonal Tumor with Abundant Neuropil and True Rosettes
• Ependymoblastoma
• Medulloblastoma
• Medulloepithelioma
• Neuroblastoma

Drugs mentioned

• DFMO (difluoromethylornithine)

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma, Medulloblastoma | Status: AVAILABLE